We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.83%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.32B
AUM Growth
-$100M
(-7%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-8.94%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$30.5M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
+$27.4M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
+$26.1M |
| 4 |
ACCD
Accolade Inc
ACCD
|
+$22.7M |
| 5 |
Vor Biopharma
VOR
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$40.6M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
+$35M |
| 3 |
Exelixis
EXEL
|
+$29.6M |
| 4 |
Labcorp
LH
|
+$28.8M |
| 5 |
AFIB
Acutus Medical Inc
AFIB
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Atea Pharmaceuticals
AVIR
$380M
| $82.7M | 6.27% |
1,338,884
-153,206
| -10% | -$10.4M |
|
2
Evolent Health
EVH
$522M
| $35.3M | 2.67% |
1,746,638
-301,619
| -15% | -$5.74M |
|
3
Novavax
NVAX
$1.29B
| $34.7M | 2.63% |
191,200
-32,150
| -14% | -$6.41M |
|
|
OCDX
4
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $33.4M | 2.53% |
+1,730,500
| New | +$30.5M |
|
5
Teleflex
TFX
$5.81B
| $33.2M | 2.51% |
79,818
-6,375
| -7% | -$2.55M |
|
|
PPD
6
DELISTED
PPD, Inc. Common Stock
PPD
| $32.3M | 2.45% |
852,525
-124,629
| -13% | -$4.47M |
|
7
Arvinas
ARVN
$524M
| $31.1M | 2.36% |
470,042
-62,083
| -12% | -$4.75M |
|
8
AtriCure
ATRC
$1.67B
| $30.8M | 2.33% |
469,867
-174,350
| -27% | -$10.7M |
|
|
RCM
9
DELISTED
R1 RCM Inc. Common Stock
RCM
| $26.4M | 2% |
1,067,768
-106,625
| -9% | -$2.82M |
|
|
10
Arcutis Biotherapeutics
ARQT
$3.42B
| $25.4M | 1.93% |
+878,948
| New | +$27.4M |
|
11
TG Therapeutics
TGTX
$8.5B
| $24.8M | 1.88% |
513,649
+307,100
| +149% | +$14.8M |
|
|
TPTX
12
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $24.4M | 1.85% |
257,879
+500
| +0.2% | +$59.5K |
|
13
Repligen
RGEN
$7.76B
| $24.2M | 1.84% |
124,693
+500
| +0.4% | +$103K |
|
14
Arcus Biosciences
RCUS
$3.74B
| $24.1M | 1.83% |
859,210
-1,950
| -0.2% | -$67.9K |
|
15
PTC Therapeutics
PTCT
$6.51B
| $23.9M | 1.81% |
504,928
-99,050
| -16% | -$5.88M |
|
16
Alignment Healthcare
ALHC
$4.13B
| $23.1M | 1.75% |
+1,052,987
| New | +$20.6M |
|
|
17
Vor Biopharma
VOR
$1.03B
| $23.1M | 1.75% |
+26,763
| New | +$22.6M |
|
18
Teladoc Health
TDOC
$1.56B
| $22.7M | 1.72% |
124,713
-85,146
| -41% | -$19.7M |
|
|
ARNA
19
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $22.3M | 1.69% |
321,659
+1,600
| +0.5% | +$123K |
|
|
NVTA
20
DELISTED
Invitae Corporation
NVTA
| $21.9M | 1.66% |
+573,759
| New | +$26.1M |
|
|
ACCD
21
DELISTED
Accolade Inc
ACCD
| $21.4M | 1.62% |
+470,750
| New | +$22.7M |
|
|
22
Labcorp
LH
$23.9B
| $20.1M | 1.52% |
91,737
-143,667
| -61% | -$28.8M |
|
23
Rocket Pharmaceuticals
RCKT
$358M
| $19.9M | 1.51% |
447,885
+80,500
| +22% | +$4.42M |
|
24
Zimmer Biomet
ZBH
$17.3B
| $19.3M | 1.46% |
124,115
-515
| -0.4% | -$79.8K |
|
|
OSH
25
DELISTED
Oak Street Health, Inc.
OSH
| $19.1M | 1.45% |
351,250
+101,250
| +41% | +$5.63M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, Sectoral Asset Management held 135 positions worth $1.32B, down 7% from $1.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Sectoral Asset Management withdrew a net $118M in Q1 2021, closing 22 positions and reducing 44 holdings. Its most notable exit was Acadia Pharmaceuticals, an estimated $35M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares worth $33.4M.
- Sectoral Asset Management's largest Q1 2021 buy was Ortho Clinical Diagnostics Holdings plc Ordinary Shares: 1,730,500 shares worth $33.4M.
- Sectoral Asset Management added most to TG Therapeutics in Q1 2021, an estimated $14.8M increase.
- Sectoral Asset Management's biggest Q1 2021 reduction was Tandem Diabetes Care, cutting an estimated $40.6M.
- Sectoral Asset Management fully exited Acadia Pharmaceuticals in Q1 2021, selling an estimated $35M.
- Sectoral Asset Management's ten largest holdings make up 28% of its $1.32B portfolio in Q1 2021.
- Sectoral Asset Management opened 38 new positions and closed 22 in Q1 2021.
- Sectoral Asset Management's portfolio value fell 7% quarter-over-quarter to $1.32B.
Based on Sectoral Asset Management's 13F filing for Q1 2021, filed 14 May 2021.